Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.

Given the known deleterious effects seen with bicarbonate supplementation for acidemia, we hypothesized that utilizing high bicarbonate concentration replacement solution in continuous venovenous hemofiltration (CVVH) would be independently associated with higher mortality.In a propensity score-matc...

Full description

Bibliographic Details
Main Authors: Kianoush Kashani, Charat Thongprayoon, Wisit Cheungpasitporn, Gina M Iacovella, Abbasali Akhoundi, Robert C Albright
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5619733?pdf=render
id doaj-16bdc49b6b0e4ce6927435ab071b3f33
record_format Article
spelling doaj-16bdc49b6b0e4ce6927435ab071b3f332020-11-25T01:42:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018506410.1371/journal.pone.0185064Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.Kianoush KashaniCharat ThongprayoonWisit CheungpasitpornGina M IacovellaAbbasali AkhoundiRobert C AlbrightGiven the known deleterious effects seen with bicarbonate supplementation for acidemia, we hypothesized that utilizing high bicarbonate concentration replacement solution in continuous venovenous hemofiltration (CVVH) would be independently associated with higher mortality.In a propensity score-matched historical cohort study conducted at a single tertiary care center from December 9, 2006, through December 31, 2009, a total of 287consecutive adult critically ill patients with Stage III acute kidney injury (AKI) requiring CVVH were enrolled. We excluded patients on maintenance dialysis, those who received other modalities of continuous renal replacement therapies, and patients that received a mixed of 22 and 32 mEq/L bicarbonate solution pre- and post-filter. The primary outcome was in-hospital and 90-day mortality rates.Among enrollees, 68 were used 32 mEq/L bicarbonate solution, and 219 received 22mEq/L bicarbonate solution for CVVH. Patients on 32 mEq/L bicarbonate solution were more often non-surgical, had lower pH and bicarbonate level but had higher blood potassium and phosphorus levels in comparison with those on 22 mEq/L bicarbonate solution. After adjustment for the baseline characteristics, the use of 32 bicarbonate solution was significantly associated with increased in-hospital (HR = 1.94; 95% CI 1.02-3.79) and 90-day mortality (HR = 1.50; 95% CI 1.03-2.14). There was a significant increase in the hospital (p = .03) and 90-day (p = .04) mortality between the 22 vs. 32 mEq/L bicarbonate solution groups following propensity matching.Our data showed there is a strong association between using high bicarbonate solution and mortality independent of severity of illness and comorbid conditions. These findings need to be evaluated further in prospective studies.http://europepmc.org/articles/PMC5619733?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kianoush Kashani
Charat Thongprayoon
Wisit Cheungpasitporn
Gina M Iacovella
Abbasali Akhoundi
Robert C Albright
spellingShingle Kianoush Kashani
Charat Thongprayoon
Wisit Cheungpasitporn
Gina M Iacovella
Abbasali Akhoundi
Robert C Albright
Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.
PLoS ONE
author_facet Kianoush Kashani
Charat Thongprayoon
Wisit Cheungpasitporn
Gina M Iacovella
Abbasali Akhoundi
Robert C Albright
author_sort Kianoush Kashani
title Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.
title_short Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.
title_full Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.
title_fullStr Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.
title_full_unstemmed Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study.
title_sort association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: a propensity-matched cohort study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Given the known deleterious effects seen with bicarbonate supplementation for acidemia, we hypothesized that utilizing high bicarbonate concentration replacement solution in continuous venovenous hemofiltration (CVVH) would be independently associated with higher mortality.In a propensity score-matched historical cohort study conducted at a single tertiary care center from December 9, 2006, through December 31, 2009, a total of 287consecutive adult critically ill patients with Stage III acute kidney injury (AKI) requiring CVVH were enrolled. We excluded patients on maintenance dialysis, those who received other modalities of continuous renal replacement therapies, and patients that received a mixed of 22 and 32 mEq/L bicarbonate solution pre- and post-filter. The primary outcome was in-hospital and 90-day mortality rates.Among enrollees, 68 were used 32 mEq/L bicarbonate solution, and 219 received 22mEq/L bicarbonate solution for CVVH. Patients on 32 mEq/L bicarbonate solution were more often non-surgical, had lower pH and bicarbonate level but had higher blood potassium and phosphorus levels in comparison with those on 22 mEq/L bicarbonate solution. After adjustment for the baseline characteristics, the use of 32 bicarbonate solution was significantly associated with increased in-hospital (HR = 1.94; 95% CI 1.02-3.79) and 90-day mortality (HR = 1.50; 95% CI 1.03-2.14). There was a significant increase in the hospital (p = .03) and 90-day (p = .04) mortality between the 22 vs. 32 mEq/L bicarbonate solution groups following propensity matching.Our data showed there is a strong association between using high bicarbonate solution and mortality independent of severity of illness and comorbid conditions. These findings need to be evaluated further in prospective studies.
url http://europepmc.org/articles/PMC5619733?pdf=render
work_keys_str_mv AT kianoushkashani associationbetweenmortalityandreplacementsolutionbicarbonateconcentrationincontinuousrenalreplacementtherapyapropensitymatchedcohortstudy
AT charatthongprayoon associationbetweenmortalityandreplacementsolutionbicarbonateconcentrationincontinuousrenalreplacementtherapyapropensitymatchedcohortstudy
AT wisitcheungpasitporn associationbetweenmortalityandreplacementsolutionbicarbonateconcentrationincontinuousrenalreplacementtherapyapropensitymatchedcohortstudy
AT ginamiacovella associationbetweenmortalityandreplacementsolutionbicarbonateconcentrationincontinuousrenalreplacementtherapyapropensitymatchedcohortstudy
AT abbasaliakhoundi associationbetweenmortalityandreplacementsolutionbicarbonateconcentrationincontinuousrenalreplacementtherapyapropensitymatchedcohortstudy
AT robertcalbright associationbetweenmortalityandreplacementsolutionbicarbonateconcentrationincontinuousrenalreplacementtherapyapropensitymatchedcohortstudy
_version_ 1725037278141612032